FDA Drug Application (201914) for RIZATRIPTAN BENZOATE by GLENMARK GENERICS

Back to FDA Applications sponsored by GLENMARK GENERICS

Application Number201914
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
DosageEQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRIZATRIPTAN BENZOATE
Active IngredientRIZATRIPTAN BENZOATE

Active IngredientCount
List of drugs with Active Ingredient RIZATRIPTAN BENZOATE3


Back to FDA Applications sponsored by GLENMARK GENERICS